Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.09 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: gsk2256294, ar9281 | 0.90 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 7 Parkinson's papers of 379 | 0.73 |
| pathways Reactome | Reactome did not answer (Reactome: HTTP 429) | 0.00 |
No case: the score is under the bar. Receipt 3054
Sealed predictions
- EPHX2 in dopamine neurons, braak-0.82 (p 0.006) → -0.04 (p 0.927)receipt 3061
Swarm cases
receipt 3061: EPHX2 in dopamine neurons, braak
- power
- full sample -0.56 (p 0.015, n 18), 95% CI -0.82 to -0.13. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.51 (p 0.029, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.62 (p 0.0057, n 18). not the mix.
- skeptic
- leave-one-out range -0.66 to -0.51, sign flips 0; without severely affected donors -0.56 (p 0.015, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EPHX2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts